Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

002873 Guiyang Xintian Pharmaceutical

14.660
+0.430+3.02%
Market Close 09/30 15:00 CCT
High
14.770
Open
14.240
Turnover
59.55M
Low
14.100
Pre Close
14.230
Volume
40.82K
Market Cap
2.43B
P/E(TTM)
21.85
52wk High
28.050
Shares
165.73M
P/E(Static)
24.15
52wk Low
12.240
Float Cap
2.32B
Bid/Ask %
-50.96%
Historical High
28.050
Shs Float
158.18M
Volume Ratio
2.17
Historical Low
8.885
Dividend TTM
0.12
Div Yield TTM
--
P/B
2.60
Dividend LFY
0.82%
Div Yield LFY
--
Turnover Ratio
2.58%
Amplitude
4.71%
Avg Price
14.588
Lot Size
100
Float Cap
2.32B
Bid/Ask %
-50.96%
Historical High
28.050
Shs Float
158.18M
Volume Ratio
2.17
Historical Low
8.885
Dividend TTM
0.12
Limit Up
15.650
P/B
2.60
Dividend LFY
0.82%
Limit Down
12.810
Turnover Ratio
2.58%
Amplitude
4.71%
Avg Price
14.588
Lot Size
100
Ask
18.37Klots
Bid
22.54Klots
Price Forecast

No Data

News

Comment

Company Overview More
The company was founded in August 1995, is a collection of new drug research and development, drug production and sales as one of the national high-tech enterprises, national national special needs commodity production enterprises, agricultural industrialization national key leading enterprises. Listed on the small and medium-sized Enterprises Board of the Shenzhen Stock Exchange on May 19, 2017, the stock code: 002873. The company is mainly engaged in the use of drugs for gynecological and urinary diseases. The company's main products: Kuntai capsule, Ningbitai capsule, Sophora flavescens gel, Prunella vulgaris oral liquid, Phellodendron Phellodendri capsule, Tiaojing Huoxue capsule, Danggui Yixue oral liquid, Xinlikang capsule, Rilinqing tablet, Xinlikang granule, Longzhang oral liquid, Ganmao Zhike capsule, Relinqing syrup, Xiaoyu Jiangzhi capsule. Corporate honor: in November 1997, the company was jointly named as "National designated production Enterprise of ethnic articles" by the State Economic and Trade Commission, Ministry of Finance and State Administration of Taxation; in October 1998, "Ningbitai capsule" became one of the first ethnic medicine products recommended by China ethnic Medical Association; in July 1999, four kinds of new drugs of traditional Chinese medicine, "Prunella vulgaris Oral liquid", passed the review of the State Drug Administration, and obtained the new drug certificate and approval document number. The company's capsule and granule production line successfully passed the GMP certification in December 2000, and obtained the "Drug GMP Certificate" in January 2001. 30 million oral liquid production workshops began to break ground in November 2002 and were completed and put into production at the end of 2003.
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...